Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France

Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi...

Dr Amy Johnson – The Ohio State University, Columbus, USA

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )

Will chemotherapy remain the cornerstone of CLL management?

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany

Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA

Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA

History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )

Translational research and the future of CLL treatment

Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA

Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )

Mapping the relationship between genetics and the impact of aspirin on...

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA

Mapping the relationship between genetics and the impact of aspirin on colorectal cancer ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )

Why doesn’t aspirin protect everyone from colorectal cancer?

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA

Why doesn’t aspirin protect everyone from colorectal cancer? ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )

Conference overview: Aspirin in the 21st Century

Prof Peter Rothwell – The University of Oxford, Oxford, UK

Conference overview: Aspirin in the 21st Century ( Prof Peter Rothwell – The University of Oxford, Oxford, UK )

Aspirin for cancer treatment and prevention

Prof Peter Elwood – Cardiff University, Cardiff, UK

Aspirin for cancer treatment and prevention ( Prof Peter Elwood – Cardiff University, Cardiff, UK )

Opportunities for treating cancer with aspirin

Dr Ruth Langley - University College London, London, UK

Opportunities for treating cancer with aspirin ( Dr Ruth Langley - University College London, London, UK )

Rethinking the mechanism of aspirin

Dr Joan Clària – University of Barcelona, Barcelona, Spain

Rethinking the mechanism of aspirin ( Dr Joan Clària – University of Barcelona, Barcelona, Spain )

More from ecancer